Back to Search
Start Over
The enigma of DNA methylation in the mammalian oocyte [version 1; peer review: 4 approved]
- Source :
- F1000Research. 9:F1000 Faculty Rev-146
- Publication Year :
- 2020
- Publisher :
- London, UK: F1000 Research Limited, 2020.
-
Abstract
- The mammalian genome experiences profound setting and resetting of epigenetic patterns during the life-course. This is understood best for DNA methylation: the specification of germ cells, gametogenesis, and early embryo development are characterised by phases of widespread erasure and rewriting of methylation. While mitigating against intergenerational transmission of epigenetic information, these processes must also ensure correct genomic imprinting that depends on faithful and long-term memory of gamete-derived methylation states in the next generation. This underscores the importance of understanding the mechanisms of methylation programming in the germline. De novo methylation in the oocyte is of particular interest because of its intimate association with transcription, which results in a bimodal methylome unique amongst mammalian cells. Moreover, this methylation landscape is entirely set up in a non-dividing cell, making the oocyte a fascinating model system in which to explore mechanistic determinants of methylation. Here, we summarise current knowledge on the oocyte DNA methylome and how it is established, focussing on recent insights from knockout models in the mouse that explore the interplay between methylation and chromatin states. We also highlight some remaining paradoxes and enigmas, in particular the involvement of non-nuclear factors for correct de novo methylation.
- Subjects :
- Review
Articles
DNA methylation
oocyte
chromatin
Subjects
Details
- ISSN :
- 20461402
- Volume :
- 9
- Database :
- F1000Research
- Journal :
- F1000Research
- Notes :
- Editorial Note on the Review Process F1000 Faculty Reviews are commissioned from members of the prestigious F1000 Faculty and are edited as a service to readers. In order to make these reviews as comprehensive and accessible as possible, the referees provide input before publication and only the final, revised version is published. The referees who approved the final version are listed with their names and affiliations but without their reports on earlier versions (any comments will already have been addressed in the published version). The referees who approved this article are: Wei Xie, School of Life Sciences, Tsinghua University, Beijing, China No competing interests were disclosed. Taiping Chen, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX, USA No competing interests were disclosed. Hiroyuki Sasaki, Division of Epigenomics and Development, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan No competing interests were disclosed. Matthew Lorincz, Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada No competing interests were disclosed., , [version 1; peer review: 4 approved]
- Publication Type :
- Academic Journal
- Accession number :
- edsfor.10.12688.f1000research.21513.1
- Document Type :
- review
- Full Text :
- https://doi.org/10.12688/f1000research.21513.1